JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells. JW Shinyak Corporation was founded in 1981 and is headquartered in Gwacheon-si, South Korea.
Metrics to compare | 067290 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship067290PeersSector | |
---|---|---|---|---|
P/E Ratio | 15.5x | 4.8x | −0.5x | |
PEG Ratio | 0.14 | 0.02 | 0.00 | |
Price/Book | 2.9x | 0.8x | 2.6x | |
Price / LTM Sales | 0.8x | 0.8x | 3.0x | |
Upside (Analyst Target) | - | 43.6% | 54.7% | |
Fair Value Upside | Unlock | 25.0% | 8.4% | Unlock |